P72.06 NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME. Xia, L., Wang, H., Dong, H., Wang, Y., & Lu, S. Journal of Thoracic Oncology, 2021.
P72.06 NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME [link]Paper  bibtex   
@article{1030,
  author = {Leiming Xia and H. Wang and Haibo Dong and Y. Wang and Sumin Lu},
  title = {P72.06 NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME},
  year = {2021},
  journal = {Journal of Thoracic Oncology},
  url = {https://doi.org/10.1016/j.jtho.2021.01.1024}
}

Downloads: 0